BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A reviewWorld Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
2
Umair Sohail, Sanjaya K. Satapathy. Diagnosis and Management of Alcoholic HepatitisClinics in Liver Disease 2012; 16(4): 717 doi: 10.1016/j.cld.2012.08.005
3
Moon-Sun Kim, Madeleine Ong, Xianqin Qu. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?World Journal of Gastroenterology 2016; 22(1): 8-23 doi: 10.3748/wjg.v22.i1.8
4
Tao Zeng, Cui-Li Zhang, Mo Xiao, Rui Yang, Ke-Qin Xie. Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical TrialsFrontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00538
5
Juan Caballeria. Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?Gastroenterología y Hepatología (English Edition) 2016; 39(8): 560 doi: 10.1016/j.gastre.2016.07.004
6
Francesco Giuseppe Foschi, Fabio Caputo, Anna Chiara Dall’Aglio, Giorgio Zoli, Mauro Bernardi, Francesco Chiappellli, Giuseppe Francesco Stefanini. Evidence-Based Practice: Toward Optimizing Clinical Outcomes2010; : 173 doi: 10.1007/978-3-642-05025-1_11
7
Tom Luedde, Neil Kaplowitz, Robert F. Schwabe. Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical RelevanceGastroenterology 2014; 147(4): 765 doi: 10.1053/j.gastro.2014.07.018
8
Lee Suan Chua. Review on Liver Inflammation and Antiinflammatory Activity of Andrographis paniculata for HepatoprotectionPhytotherapy Research 2014; 28(11): 1589 doi: 10.1002/ptr.5193
9
Alexandre Louvet, Mark R. Thursz, Dong Joon Kim, Julien Labreuche, Stephen R. Atkinson, Sandeep Singh Sidhu, John G. O’Grady, Evangelos Akriviadis, Emmanouil Sinakos, Robert L. Carithers, Marie-José Ramond, Willis C. Maddrey, Timothy R. Morgan, Alain Duhamel, Philippe Mathurin. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data From Controlled TrialsGastroenterology 2018; 155(2): 458 doi: 10.1053/j.gastro.2018.05.011
10
Ashwani K Singal, Ishmeet Walia, Anjna Singal, Roger D Soloway. Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current statusWorld Journal of Hepatology 2011; 3(8): 205-210 doi: 10.4254/wjh.v3.i8.205
11
Jonathan R Potts, Sumita Verma. Alcoholic hepatitis: diagnosis and management in 2012Expert Review of Gastroenterology & Hepatology 2012; 6(6): 695 doi: 10.1586/egh.12.57
12
Vijay H. Shah. Alcoholic liver disease: The buzz may be gone, but the hangover remainsHepatology 2010; 51(5): 1483 doi: 10.1002/hep.23686
13
Jessica Williams, Wen-Xing Ding. A Mechanistic Review of Mitophagy and Its Role in Protection against Alcoholic Liver DiseaseBiomolecules 2015; 5(4): 2619 doi: 10.3390/biom5042619
14
Diana V Avila, David F Barker, JingWen Zhang, Craig J McClain, Shirish Barve, Leila Gobejishvili. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosisThe Journal of Pathology 2016; 240(1): 96 doi: 10.1002/path.4760
15
Juliane I. Beier, Gavin E. Arteel, Craig J. McClain. Advances in Alcoholic Liver DiseaseCurrent Gastroenterology Reports 2011; 13(1): 56 doi: 10.1007/s11894-010-0157-5
16
Elena Buzzetti, Maria Kalafateli, Douglas Thorburn, Brian R Davidson, Maja Thiele, Lise Lotte Gluud, Cinzia Del Giovane, Gro Askgaard, Aleksander Krag, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)Cochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011646.pub2
17
B. Dupont, T. Dao, M. -A. Piquet. Hépatite alcoolique aiguë : prise en charge en 2011Réanimation 2011; 20(4): 335 doi: 10.1007/s13546-011-0276-5
18
Patricia E. Molina, Jason D. Gardner, Flavia M. Souza-Smith, Annie M. Whitaker. Alcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease BurdenPhysiology 2014; 29(3): 203 doi: 10.1152/physiol.00055.2013
19
Grzegorz Wystrychowski, Wojciech Wystrychowski, Władysław Grzeszczak, Andrzej Więcek, Robert Król, Antoni Wystrychowski. Pentoxifylline and Methylprednisolone Additively Alleviate Kidney Failure and Prolong Survival of Rats after Renal Warm Ischemia-ReperfusionInternational Journal of Molecular Sciences 2018; 19(1): 221 doi: 10.3390/ijms19010221
20
Jeongeun Hyun, Zhaoli Sun, Ali Reza Ahmadi, Sushant Bangru, Ullas V. Chembazhi, Kuo Du, Tianyi Chen, Hidekazu Tsukamoto, Ivan Rusyn, Auinash Kalsotra, Anna Mae Diehl. Epithelial splicing regulatory protein 2–mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitisJournal of Clinical Investigation 2020; 130(4): 2129 doi: 10.1172/JCI132691
21
Ashwani K. Singal, Sudha Kodali, Lee A. Vucovich, Victor Darley-Usmar, Thomas D. Schiano. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic ReviewAlcoholism: Clinical and Experimental Research 2016; 40(7): 1390 doi: 10.1111/acer.13108
22
Dolores Morrison, Justine Sgrillo, Lauren H. Daniels. Managing alcoholic liver diseaseNursing 2014; 44(11): 30 doi: 10.1097/01.NURSE.0000454950.13699.e0
23
K.J. Senthil Kumar, Fang-Hua Chu, Han-Wen Hsieh, Jiunn-Wang Liao, Wen-Hsiung Li, Johnson Chin-Chung Lin, Jei-Fu Shaw, Sheng-Yang Wang. Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activationJournal of Ethnopharmacology 2011; 136(1): 168 doi: 10.1016/j.jep.2011.04.030
24
Roopjeet K. Bath, George Y. Wu. Pocket Handbook of GI PharmacotherapeuticsClinical Gastroenterology 2016; : 113 doi: 10.1007/978-3-319-33317-5_8
25
Yingfeng Tu, Shu Zhu, Jing Wang, Ezra Burstein, Da Jia. Natural compounds in the chemoprevention of alcoholic liver diseasePhytotherapy Research 2019; 33(9): 2192 doi: 10.1002/ptr.6410
26
Philippe Mathurin, Michael R. Lucey. Management of alcoholic hepatitisJournal of Hepatology 2012; 56: S39 doi: 10.1016/S0168-8278(12)60005-1
27
Ashwani K. Singal, Patrick S. Kamath, Gregory J. Gores, Vijay H. Shah. Alcoholic Hepatitis: Current Challenges and Future DirectionsClinical Gastroenterology and Hepatology 2014; 12(4): 555 doi: 10.1016/j.cgh.2013.06.013
28
Mack C. Mitchell, Lawrence S. Friedman, Craig J. McClain. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA InstituteClinical Gastroenterology and Hepatology 2017; 15(1): 5 doi: 10.1016/j.cgh.2016.08.047
29
Rakhi Maiwall, S. K. Sarin, Richard Moreau. Acute kidney injury in acute on chronic liver failureHepatology International 2016; 10(2): 245 doi: 10.1007/s12072-015-9652-y
30
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and managementNature Reviews Gastroenterology & Hepatology 2016; 13(3): 131 doi: 10.1038/nrgastro.2015.219
31
Srinivasan Dasarathy, Mack C. Mitchell, Bruce Barton, Craig J. McClain, Gyongyi Szabo, Laura E. Nagy, Svetlana Radaeva, Arthur J. McCullough. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitisContemporary Clinical Trials 2020; 96: 106094 doi: 10.1016/j.cct.2020.106094
32
Jacyntha A. Sterling. Recent Publications on Medications and PharmacyHospital Pharmacy 2009; 44(6): 526 doi: 10.1310/hpj4406-526
33
Siddharth Singh, Mohammad Hassan Murad, Apoorva K. Chandar, Connie M. Bongiorno, Ashwani K. Singal, Stephen R. Atkinson, Mark R. Thursz, Rohit Loomba, Vijay H. Shah. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysisGastroenterology 2015; 149(4): 958 doi: 10.1053/j.gastro.2015.06.006
34
Mark R. Thursz, Paul Richardson, Michael Allison, Andrew Austin, Megan Bowers, Christopher P. Day, Nichola Downs, Dermot Gleeson, Alastair MacGilchrist, Allister Grant, Steven Hood, Steven Masson, Anne McCune, Jane Mellor, John O’Grady, David Patch, Ian Ratcliffe, Paul Roderick, Louise Stanton, Nikhil Vergis, Mark Wright, Stephen Ryder, Ewan H. Forrest. Prednisolone or Pentoxifylline for Alcoholic HepatitisNew England Journal of Medicine 2015; 372(17): 1619 doi: 10.1056/NEJMoa1412278
35
Young-Sun Lee, Hyun Jung Kim, Ji Hoon Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Jae Seon Kim, Jong-Jae Park, Soon Ho Um, Young-Tae Bak, Kwan Soo Byun. Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual TherapyJournal of Clinical Gastroenterology 2017; 51(4): 364 doi: 10.1097/MCG.0000000000000674
36
Alexandre Louvet, Philippe Mathurin. Alcoholic liver disease: mechanisms of injury and targeted treatmentNature Reviews Gastroenterology & Hepatology 2015; 12(4): 231 doi: 10.1038/nrgastro.2015.35
37
Ashwani K. Singal, Vijay H. Shah. Alcoholic Hepatitis: Prognostic Models and TreatmentGastroenterology Clinics of North America 2011; 40(3): 611 doi: 10.1016/j.gtc.2011.06.008
38
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang. Revision and update on clinical practice guideline for liver cirrhosisThe Korean Journal of Hepatology 2012; 18(1): 1 doi: 10.3350/kjhep.2012.18.1.1
39
Jolene Siple, Lynnette Klaus, Kathryn S. Voll. Alcoholic hepatitis in a patient with a history of daily beer consumptionJournal of the American Academy of Physician Assistants 2010; 23(11): E1 doi: 10.1097/01720610-201011000-00024
40
Robin Arora, Shweta Kathuria, Nishant Jalandhara. Acute renal dysfunction in patients with alcoholic hepatitisWorld Journal of Hepatology 2011; 3(5): 121-124 doi: 10.4254/wjh.v3.i5.121
41
Fátima Higuera-de la Tijera, Alfredo Israel Servín-Caamaño, Eduardo Pérez-Torres, Francisco Salas-Gordillo, Juan Miguel Abdo-Francis, José Luis Pérez-Hernández, David Kershenobich. Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systemsRevista Médica Del Hospital General De México 2014; 77(4): 160 doi: 10.1016/j.hgmx.2014.10.003
42
Juliane I. Beier, Craig J. McClain. Mechanisms and cell signaling in alcoholic liver diseaseBiological Chemistry 2010; 391(11) doi: 10.1515/bc.2010.137
43
KASL Clinical Practice Guidelines: Management of Alcoholic Liver DiseaseClinical and Molecular Hepatology 2013; 19(3): 216 doi: 10.3350/cmh.2013.19.3.216
44
Ashwani K Singal, Ramon Bataller, Joseph Ahn, Patrick S Kamath, Vijay H Shah. ACG Clinical Guideline: Alcoholic Liver DiseaseAmerican Journal of Gastroenterology 2018; 113(2): 175 doi: 10.1038/ajg.2017.469
45
Phoenix Fung, Nikolaos Pyrsopoulos. Emerging concepts in alcoholic hepatitisWorld Journal of Hepatology 2017; 9(12): 567-585 doi: 10.4254/wjh.v9.i12.567
46
Stelios F Assimakopoulos, Konstantinos C Thomopoulos, Chrisoula Labropoulou-Karatza. Pentoxifylline: A first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?World Journal of Gastroenterology 2009; 15(25): 3194-3195 doi: 10.3748/wjg.15.3194
47
Erin K. J. Spengler, Jeffrey Dunkelberg, Ron Schey. Alcoholic Hepatitis: Current ManagementDigestive Diseases and Sciences 2014; 59(10): 2357 doi: 10.1007/s10620-014-3173-8
48
Thomas Berg. Handbuch Gastroenterologie 20102010; : 500 doi: 10.1007/978-3-642-11635-3_14
49
Jan Petrasek, Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 291 doi: 10.1007/978-3-319-20538-0_15
50
Francisco J. Bosques-Padilla, Genaro Vázquez-Elizondo, Manuel A. Martínez Vázquez, Héctor J. Maldonado-Garza. Pentoxifylline and prednisolone in severe alcoholic hepatitisAnnals of Hepatology 2009; 8(4): 402 doi: 10.1016/S1665-2681(19)31760-0
51
A.M. Müller-Marbach, D. Häussinger, L.C. Rump, O. Vonend. Das hepatorenale SyndromDer Nephrologe 2010; 5(1): 29 doi: 10.1007/s11560-009-0339-z
52
R. Parker, M. J. Armstrong, C. Corbett, I. A. Rowe, D. D. Houlihan. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitisAlimentary Pharmacology & Therapeutics 2013; 37(9): 845 doi: 10.1111/apt.12279
53
Faryal Tahir, Haris Riaz, Anis Rehman, Muhammad Bilal Munir. Potential role of TNF alpha blockers in delaying the progression of hepato-renal syndromeMedical Hypotheses 2012; 78(2): 225 doi: 10.1016/j.mehy.2011.10.030
54
Mack C. Mitchell, Gyongyi Szabo. Schiff's Diseases of the Liver2017; : 699 doi: 10.1002/9781119251316.ch26
55
Ravi Daswani, Ashish Kumar, Shrihari Anil Anikhindi, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from IndiaIndian Journal of Gastroenterology 2018; 37(2): 141 doi: 10.1007/s12664-018-0842-0
56
Ryan E. Owens, Heather S. Snyder, Jennifer D. Twilla, Sanjaya K. Satapathy. Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity StratificationJournal of Clinical and Experimental Hepatology 2016; 6(4): 275 doi: 10.1016/j.jceh.2016.07.003
57
Jennifer Casanova, Ramón Bataller. Alcoholic hepatitis: Prognosis and treatmentGastroenterología y Hepatología 2014; 37(4): 262 doi: 10.1016/j.gastrohep.2014.02.001
58
Seung Ha Park, Dong Joon Kim, Young Seok Kim, Hyung Joon Yim, Won Young Tak, Heon Ju Lee, Joo Hyun Sohn, Ki Tae Yoon, In Hee Kim, Hyoung Su Kim, Soon Ho Um, Soon Koo Baik, June Sung Lee, Ki Tae Suk, Sang Gyune Kim, Sang Jun Suh, Soo Young Park, Tae Yeob Kim, Jae Young Jang. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: A randomised, non-inferiority, open trialJournal of Hepatology 2014; 61(4): 792 doi: 10.1016/j.jhep.2014.05.014
59
Sandeep Singh Sidhu, Omesh Goyal, Preeti Singla, Dinesh Gupta, Ajit Sood, Rajoo Singh Chhina, Ravinder Kumar Soni. Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)Digestive Diseases and Sciences 2012; 57(6): 1664 doi: 10.1007/s10620-012-2097-4
60
Dolores Morrison, Justine Sgrillo, Lauren H. Daniels. Tratamiento de la hepatopatía alcohólicaNursing (Ed. española) 2015; 32(4): 18 doi: 10.1016/j.nursi.2015.08.010
61
Basile Njei, Albert Do, Thomas R. McCarty, Brett E. Fortune. Corticosteroids Versus Pentoxifylline for Severe Alcoholic HepatitisJournal of Clinical Gastroenterology 2016; 50(10): 871 doi: 10.1097/MCG.0000000000000585
62
Zhanxiang Zhou, Ross E. Jones, Craig J. McClain. HIV and Liver Disease2012; : 45 doi: 10.1007/978-1-4419-1712-6_6
63
Fátima Higuera-de la Tijera, Alfredo I Servín-Caamaño, Aurora E Serralde-Zúñiga, Javier Cruz-Herrera, Eduardo Pérez-Torres, Juan M Abdo-Francis, Francisco Salas-Gordillo, José L Pérez-Hernández. Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitisWorld Journal of Gastroenterology 2015; 21(16): 4975-4985 doi: 10.3748/wjg.v21.i16.4975
64
Jennifer T. Wells, Michael R. Lucey. Textbook of Clinical Gastroenterology and Hepatology2012; : 649 doi: 10.1002/9781118321386.ch88
65
Ahmed A.M. Abdel-Hamid, Eyad M.T. Ali. Pentoxifylline attenuates hepatic fibrosis by inhibiting hepatic stellate cellsThe Egyptian Journal of Histology 2015; 38(2): 378 doi: 10.1097/01.EHX.0000464787.34981.cc
66
Ki Tae Suk, Moon Young Kim, Soon Koo Baik. Alcoholic liver disease: TreatmentWorld Journal of Gastroenterology 2014; 20(36): 12934-12944 doi: 10.3748/wjg.v20.i36.12934
67
Puiyan Lam, Fan Cheung, Hor Tan, Ning Wang, Man Yuen, Yibin Feng. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesInternational Journal of Molecular Sciences 2016; 17(4): 465 doi: 10.3390/ijms17040465
68
Juan Caballeria. Is petoxifylline still an option in severe alcoholic hepatitis?Hepatology 2015; 61(4): 1425 doi: 10.1002/hep.27657
69
B. Javier Brahm, P. Rodrigo Quera. Síndrome hepatorenal: patogénesis y tratamientoRevista Médica Clínica Las Condes 2010; 21(4): 613 doi: 10.1016/S0716-8640(10)70577-0
70
Naga P. Chalasani. Goldman's Cecil Medicine2012; : 996 doi: 10.1016/B978-1-4377-1604-7.00155-X
71
Laura Smart, Leila Gobejishvili, Neil Crittenden, Shirish Barve, Craig J. McClain. Alcoholic Hepatitis: Steroids vs. PentoxifyllineCurrent Hepatitis Reports 2013; 12(1): 59 doi: 10.1007/s11901-012-0158-y
72
Laxman Singh, Tanuj Joshi, Devesh Tewari, Javier Echeverría, Andrei Mocan, Archana N. Sah, Emil Parvanov, Nikolay T. Tzvetkov, Zheng Feei Ma, Yeong Yeh Lee, Piotr Poznański, Lukasz Huminiecki, Mariusz Sacharczuk, Artur Jóźwik, Jarosław O. Horbańczuk, Joanna Feder-Kubis, Atanas G. Atanasov. Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and OutlookFrontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01593
73
Ashwani K. Singal, Vijay H. Shah. Zakim and Boyer's Hepatology2018; : 351 doi: 10.1016/B978-0-323-37591-7.00024-0
74
Radan Bruha, Karel Dvorak, Jaromir Petrtyl. Alcoholic liver diseaseWorld Journal of Hepatology 2012; 4(3): 81-90 doi: 10.4254/wjh.v4.i3.81
75
Yoshinori Horie. Granulocytapheresis and plasma exchange for severe alcoholic hepatitisJournal of Gastroenterology and Hepatology 2012; 27: 99 doi: 10.1111/j.1440-1746.2011.07005.x
76
Ewan Forrest, Jane Mellor, Louise Stanton, Megan Bowers, Priscilla Ryder, Andrew Austin, Christopher Day, Dermot Gleeson, John O’Grady, Steven Masson, Anne McCune, David Patch, Paul Richardson, Paul Roderick, Stephen Ryder, Mark Wright, Mark Thursz. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trialTrials 2013; 14(1): 262 doi: 10.1186/1745-6215-14-262
77
Thomas H. Frazier, Abigail M. Stocker, Nicole A. Kershner, Luis S. Marsano, Craig J. McClain. Treatment of alcoholic liver diseaseTherapeutic Advances in Gastroenterology 2011; 4(1): 63 doi: 10.1177/1756283X10378925
78
Juan Caballeria. ¿Tiene algún papel la pentoxifilina en el tratamiento de la hepatitis alcohólica?Gastroenterología y Hepatología 2016; 39(8): 560 doi: 10.1016/j.gastrohep.2015.10.004
79
Gina Choi, Bruce Allen Runyon. Alcoholic Hepatitis: A Clinician’s GuideClinics in Liver Disease 2012; 16(2): 371 doi: 10.1016/j.cld.2012.03.015
80
Vassilios Papastergiou, Andrew K Burroughs, Emmanuel A Tsochatzis. Prognosis and treatment of patients with acute alcoholic hepatitisExpert Review of Gastroenterology & Hepatology 2014; 8(5): 471 doi: 10.1586/17474124.2014.903800
81
Mark Thursz, Timothy R. Morgan. Treatment of Severe Alcoholic HepatitisGastroenterology 2016; 150(8): 1823 doi: 10.1053/j.gastro.2016.02.074
82
Stefani Vircheva, Albena Alexandrova, Almira Georgieva, Polina Mateeva, Rositza Zamfirova, Marta Kubera, Margarita Kirkova. In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammationCell Biochemistry and Function 2010; 28(8): 668 doi: 10.1002/cbf.1705
83
Ariel W. Aday, Mack C. Mitchell, Lisa C. Casey. Alcoholic hepatitisCurrent Opinion in Gastroenterology 2017; 33(3): 142 doi: 10.1097/MOG.0000000000000359
84
Walter E. Rodriguez, Banrida Wahlang, Yali Wang, Jingwen Zhang, Manicka V. Vadhanam, Swati Joshi‐Barve, Philip Bauer, Robert Cannon, Ali Reza Ahmadi, Zhaoli Sun, Andrew Cameron, Shirish Barve, Claudio Maldonado, Craig McClain, Leila Gobejishvili. Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to BenchHepatology 2019; 70(6): 1958 doi: 10.1002/hep.30761
85
Apurva Yeluru, Jennifer A. Cuthbert, Lisa Casey, Mack C. Mitchell. Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to TreatmentAlcoholism: Clinical and Experimental Research 2016; 40(2): 246 doi: 10.1111/acer.12956
86
Verena Wieser, Herbert Tilg. Management bei schwerer alkoholischer HepatitisWiener Medizinische Wochenschrift 2014; 164(1-2): 3 doi: 10.1007/s10354-013-0221-5
87
Ewan H Forrest. The management of alcoholic hepatitisBritish Journal of Hospital Medicine 2009; 70(12): 680 doi: 10.12968/hmed.2009.70.12.45503
88
Mark Thursz, Ewan Forrest, Paul Roderick, Christopher Day, Andrew Austin, John O’Grady, Stephen Ryder, Michael Allison, Dermot Gleeson, Anne McCune, David Patch, Mark Wright, Steven Masson, Paul Richardson, Luke Vale, Jane Mellor, Louise Stanton, Megan Bowers, Ian Ratcliffe, Nichola Downs, Scott Kirkman, Tara Homer, Laura Ternent. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trialHealth Technology Assessment 2015; 19(102): 1 doi: 10.3310/hta191020
89
Ashutosh Barve, Luis S. Marsano, Dipendra Parajuli, Matthew Cave, Craig J. McClain. Liver Disorders2017; : 173 doi: 10.1007/978-3-319-30103-7_13
90
Bin Gao, Ramon Bataller. Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology 2011; 141(5): 1572 doi: 10.1053/j.gastro.2011.09.002
91
A. Davenport, J. Ahmad, A. Al-Khafaji, J. A. Kellum, Y. S. Genyk, M. K. Nadim. Medical management of hepatorenal syndromeNephrology Dialysis Transplantation 2012; 27(1): 34 doi: 10.1093/ndt/gfr736
92
Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy optionsExpert Opinion on Pharmacotherapy 2018; 19(8): 779 doi: 10.1080/14656566.2018.1465929
93
EASL Clinical Practical Guidelines: Management of Alcoholic Liver DiseaseJournal of Hepatology 2012; 57(2): 399 doi: 10.1016/j.jhep.2012.04.004